For Professionals
She Gained 40 Pounds and Was Told It Wasn’t Cushing’s. Two Experts Agreed. They Were Both Wrong.
From Lewis Blevins MD, Adrenal World News cofounder, medical director of the California Center for Pituitary disorders and professor of
Dr. Blevins Corner
Pseudoscience in Endocrinology: The Adrenal Fatigue Problem
From the desk of Lewis Blevins, MD – There is no such thing as adrenal fatigue. Period. I’ve seen plenty
Of note:
Crinetics Pharmaceuticals Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)- Read more
Recordati announces FDA approval of ISTURISA® new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here
When your pituitary endocrinologist writes science fiction: introducing “2345” – Details here
Dr. Naila Goldenberg speaks about Adrenal Insufficiency and her experiences with cortisol pumps
Adrenalectomy Benefits for People with Mild Autonomous Cortisol Secretion (MACS)
Cortisol and type 2 diabetes
Disorders of cortisol secretion related to adrenal conditions
Most Popular Articles
The Podcast
Knowledge and information are critical tools affecting adrenal disease knowledge and treatments. Join the Adrenal World News podcast, as it navigates the wonders and complexities of adrenal conditions.
This is a very informative discussion about the new indications of the Cushing's Drug Isturisa® (osilodrostat) with Dr. Mario Maldonado, who heads global development for endocrinology at Recordati Rare Diseases.
In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.
Apple Podcasts
Spotify
Amazon Music
Google Podcasts
